Recent research indicates that hazelnut waste nanoparticles synthesized using soy lecithin could revolutionize the management of oxidative stress-related diseases. Researchers focused on repurposing by-products like shells, skins, and husks, which usually go to waste during food processing. Specifically, the study found that shell-derived nanoparticles possess unique structural advantages, including the smallest particle size and the highest zeta potential. These characteristics significantly enhance their bioaccessibility and therapeutic efficacy in laboratory settings.

Bioactive Potential of Hazelnut Waste Nanoparticles

The investigation highlights that shell-derived nanoparticles contain the highest concentrations of beneficial compounds. For instance, researchers measured high levels of gallic acid, rutin, and quercetin within these particles. Furthermore, the nanoparticles demonstrated impressive antioxidant properties and thermal stability. In contrast to husk and skin variants, shell-derived versions showed the greatest inhibition of lipid peroxidation. Consequently, these findings suggest a robust potential for preventing cellular damage caused by oxidative stress.

Moreover, the antidiabetic activity followed a clear hierarchy, with shell-derived particles performing best, followed by skin and then husk. The researchers also tested these formulations against specific tumor cell lines. Notably, hazelnut waste nanoparticles exhibited significant anti-proliferative effects in MCF-7 breast cancer and HT-29 colon cancer cells. This suggests that the bioactive components within the waste remain potent even after the synthesis process. Additionally, principal component analysis confirmed that antioxidant properties are the primary drivers of these therapeutic effects.

Future Implications in Clinical Nutrition

The successful recycling of hazelnut waste into functional nanoparticles offers a sustainable path for drug development. Since these materials are readily available, they provide a cost-effective source of high-value polyphenols. Physicians and nutritionists may eventually see these extracts integrated into specialized diets or supplement protocols. However, further clinical trials in human subjects are necessary to confirm these in vitro results. Nevertheless, the study provides a strong foundation for using food industry waste in medical applications.

Frequently Asked Questions

What are the primary medical benefits of hazelnut waste nanoparticles?

These nanoparticles show significant antidiabetic properties and can inhibit the growth of breast and colon cancer cell lines in laboratory environments. They are also rich in antioxidants that protect cells from oxidative stress.

Why is the shell considered the best source for these nanoparticles?

The shell-derived nanoparticles have the highest loading capacity and the best bioaccessibility for key compounds like gallic acid and quercetin. They also exhibit the smallest particle size, which improves their efficiency.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Temiz MA et al. Recycling of hazelnut waste: Antidiabetic properties of soy lecithin nanoparticles and their in vitro anti-proliferative effects in tumor cell lines. J Sci Food Agric. 2026 Mar 30. doi: 10.1002/jsfa.70615. PMID: 41913074.

Esposito T et al. Hazelnut (Corylus avellana L.) Shells Extract: Phenolic Composition, Antioxidant Effect and Cytotoxic Activity on Human Cancer Cell Lines. Int J Mol Sci. 2017;18(2):392.

Sajjadi M et al. Carbon-Based Nanomaterials for Targeted Cancer Nanotherapy: Recent Trends and Future Prospects. J Drug Target. 2021;29(7):716-741.